"Uncovering the Untapped Potential of Anti-Aging Drugs and Longevity Clinics"
TL;DR
Dr. Nir Barzilai, a leading longevity researcher, has identified four promising but overlooked anti-aging drugs: Metformin, Rapamycin, ACE inhibitors, and SGLT2 inhibitors. These drugs have shown potential in extending lifespan and improving age-related health issues, such as reducing inflammation, cancer risk, and improving immune function. Despite being already available and relatively low-cost, these drugs struggle to attract investment due to their generic nature. However, they offer potential for treating aging-related conditions and are backed by established safety and efficacy data.
Topics:healthhealth-longevity-research#aging#anti-aging-drugs#health#health-longevity-research#longevity#research
- 4 Promising Anti-Aging Drugs That Investors Are Sleeping on Business Insider
- The Wild Science of Growing Younger | Worth Worth Magazine
- 9 Expert Tips on How to Live Longer and The Best Longevity Clinics ELLE
- Aging is a Treatable Condition, says Dr. Nir Barzilai - Worth Worth Magazine
- Anti-Aging: Can We Be Forever Young? Reply All | Gimlet
Want the full story? Read the original reporting
Read on Business Insider